SEARCH

SEARCH BY CITATION

REFERENCES

  • Astrinidis A, Cash TP, Hunter DS, Walker CL, Chernoff J, Henske EP. (2002) Tuberin, the tuberous sclerosis complex 2 tumor suppressor gene product, regulates Rho activation, cell adhesion and migration. Oncogene 21:84708476.
  • Barkovich AJ, Kuzniecky RI, Jackson GD, Guerrini R, Dobyns WB. (2001) Classification system for malformations of cortical development: update 2001. Neurology 57:21682178.
  • Baybis M, Yu J, Lee A, Golden JA, Weiner H, McKhan G II, Aronica E, Crino PB. (2004) mTOR cascade activation distinguishes tubers from focal cortical dysplasias. Annals of Neurology 56:478487.
  • Becker AJ, Löbach M, Klein H, Normann S, Nöthen MM, Von Deimling A, Mizuguchi M, Elger CE, Schramm J, Wiestler OD, Blümcke I. (2001) Mutational analysis of TSC1 and TSC2 genes in gangliogliomas. Neuropathology and Applied Neurobiology 27:105114.
  • Becker AJ, Urbach H, Scheffler B, Baden T, Normann S, Lahl R, Pannek HW, Tuxhorn I, Elger CE, Schramm J, Wiestler OD, Blümcke I. (2002) Focal cortical dysplasia of Taylor's balloon cell type: mutational analysis of the TSC1 gene indicates a pathogenic relationship to tuberous sclerosis. Annals of Neurology 52:2937.
  • Blümcke I, Beck H, Lie AA, Wiestler OD. (1999a) Molecular neuropathology of human mesial temporal lobe epilepsy. Epilepsy Research 36:205223.
  • Blümcke I, Giencke K, Wardelmann E, Beyenburg S, Kral T, Sarioglu N, Pietsch T, Wolf HK, Schramm J, Elger CE, Wiestler OD. (1999b) The CD34 epitope is expressed in neoplastic and malformative lesions associated with chronic, focal epilepsies. Acta Neuropathologica 97:481490.
  • Blümcke I, Wiestler OD. (2002) Gangliogliomas: an intriguing tumor entity associated with focal epilepsies. Journal of Neuropathology and Experimental Neurology 61:575584.
  • Catania MG, Mischel PS, Vinters HV. (2001) Hamartin and tuberin interaction with the G2/M cyclin-dependent kinase CDK1 and its regulatory cyclins A and B. Journal of Neuropathology and Experimental Neurology 60:711723.
  • Cepeda C, Hurst RS, Flores-Hernandez J, Hernandez-Echeagaray E, Klapstein GJ, Boylan MK, Calvert CR, Jocoy EL, Nguyen OK, Andre VM, Vinters HV, Ariano MA, Levine MS, Mathern GW. (2003) Morphological and electrophysiological characterization of abnormal cell types in pediatric cortical dysplasia. Journal of Neuroscience Research 72:472486.
  • Dabora SL, Sigalas I, Hall F, Eng C, Vijg J, Kwiatkowski DJ. (1998) Comprehensive mutation analysis of TSC1 using two-dimensional DNA electrophoresis with DGGE. Journal of Neuroscience Research 62:491504.
  • Dan HC, Sun M, Yang L, Feldman RI, Sui XM, Ou CC, Nellist M, Yeung RS, Halley DJ, Nicosia SV, Pledger WJ, Cheng JQ. (2002) Phosphatidylinositol 3-kinase/Akt pathway regulates tuberous sclerosis tumor suppressor complex by phosphorylation of tuberin. Journal of Biological Chemistry 277:3536435370.
  • Daumas-Duport C, Scheithauer BW, Chodkiewicz JP, Laws ER, Vedrenne C. (1988) Dysembryoplastic neuroepithelial tumor: a surgically curable tumor of young patients with intractable partial seizures. Report of thirty-nine cases. Neurosurgery 23:545556.
  • Daumas-Duport C. (1993) Dysembryoplastic neuroepithelial tumours. Brain Pathology 3:283295.
  • Derouiche A, Frotscher M. (2001) Peripheral astrocyte processes: monitoring by selective immunostaining for the actin-binding ERM proteins. Glia 36:330341.
  • Duerr EM, Rollbrocker B, Hayashi Y, Peters N, Meyer-Puttlitz B, Louis DN, Schramm J, Wiestler OD, Parsons R, Eng C, Von Deimling A. (1998) PTEN mutations in gliomas and glioneuronal tumors. Oncogene 16:22592264.
  • El-Hashemite N, Zhang H, Henske EP, Kwiatkowski DJ. (2003) Mutation in TSC2 and activation of mammalian target of rapamycin signalling pathway in renal angiomyolipoma. Lancet 361:13481349.
  • Elger CE. (2002) Epilepsy: disease and model to study human brain function. Brain Pathology 12:193198.
  • Engel J Jr. (2003) A greater role for surgical treatment of epilepsy: why and when? Epilepsy Curr 3:3740.
  • Fassunke J, Blümcke I, Lahl R, Elger CE, Schramm J, Merkelbach-Bruse S, Mathiak M, Wiestler OD, Becker AJ. (2004a) Analysis of chromosomal instability in focal cortical dysplasia of Taylor's balloon cell type. Acta Neuropathologica 108:129134.
  • Fassunke J, Majores M, Ullmann C, Elger CE, Schramm J, Wiestler OD, Becker AJ. (2004b) In situ-RT and immunolaser microdissection for mRNA analysis of individual cells isolated from epilepsy-associated glioneuronal tumors. Laboratory Investigation 84:15201525.
  • Fauser S, Becker A, Schulze-Bonhage A, Hildebrandt M, Tuxhorn I, Pannek HW, Lahl R, Schramm J, Blümcke I. (2004) CD34-immunoreactive balloon cells in cortical malformations. Acta Neuropathologica 108:272278.
  • Fisher RS, Van Emde Boas W, Blume W, Elger C, Genton P, Lee P, Engel J Jr. (2005) Epileptic seizures and epilepsy: definitions proposed by the International League Against Epilepsy (ILAE) and the International Bureau for Epilepsy (IBE). Epilepsia 46:470472.
  • Gao X, Zhang Y, Arrazola P, Hino O, Kobayashi T, Yeung RS, Ru B, Pan D. (2002) TSC tumour suppressor proteins antagonize amino-acid-TOR signalling. Nature Cell Biology 4:699704.
  • Haddad LA, Smith N, Bowser M, Niida Y, Murthy V, Gonzalez-Agosti C, Ramesh V. (2002) The TSC1 tumor suppressor hamartin interacts with neurofilament-L and possibly functions as a novel integrator of the neuronal cytoskeleton. Journal of Biological Chemistry 277:4418044186.
  • Hoeflich KP, Ikura M. (2004) Radixin: cytoskeletal adopter and signaling protein. International Journal of Biochemistry and Cell Biology 36:21312136.
  • Inoki K, Li Y, Zhu T, Wu J, Guan KL. (2002) TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling. Nature Cell Biology 4:648657.
  • Ito N, Rubin GM. (1999) gigas, a Drosophila homolog of tuberous sclerosis gene product-2, regulates the cell cycle. Cell 96:529539.
  • Johnson MW, Miyata H, Vinters HV. (2002) Ezrin and moesin expression within the developing human cerebrum and tuberous sclerosis-associated cortical tubers. Acta Neuropathologica 104:188196.
  • Jones AC, Daniells CE, Snell RG, Tachataki M, Idziaszczyk SA, Krawczak M, Sampson JR, Cheadle JP. (1997) Molecular genetic and phenotypic analysis reveals differences between TSC1 and TSC2 associated familial and sporadic tuberous sclerosis. Human Molecular Genetics 6:21552161.
  • Kenerson HL, Aicher LD, True LD, Yeung RS. (2002) Activated mammalian target of rapamycin pathway in the pathogenesis of tuberous sclerosis complex renal tumors. Cancer Research 62:56455650.
  • Knudson AG. (1996) Hereditary cancer: two hits revisited. Journal of Cancer Research and Clinical Oncology 122:135140.
  • Kwiatkowski DJ. (2003) Tuberous sclerosis: from tubers to mTOR. Annals of Human Genetics 67:8796.
  • Lamb RF, Roy C, Diefenbach TJ, Vinters HV, Johnson MW, Jay DG, Hall A. (2000) The TSC1 tumour suppressor hamartin regulates cell adhesion through ERM proteins and the GTPase Rho. Nature Cell Biology 2:281287.
  • Luyken C, Blümcke I, Fimmers R, Urbach H, Elger CE, Wiestler OD, Schramm J. (2003) The spectrum of long-term epilepsy-associated tumors: long-term seizure and tumor outcome and neurosurgical aspects. Epilepsia 44:822830.
  • Luyken C, Blumcke I, Fimmers R, Urbach H, Wiestler OD, Schramm J. (2004) Supratentorial gangliogliomas: histopathologic grading and tumor recurrence in 184 patients with a median follow-up of 8 years. Cancer 101:146155.
  • Majander-Nordenswan P, Sainio M, Turunen O, Jaaskelainen J, Carpen O, Kere J, Vaheri A. (1998) Genomic structure of the human ezrin gene. Human Genetics 103:662665.
  • Majores M, Blümcke I, Urbach H, AM, Hans V, Holthausen H, Elger CE, Schramm J, Galli C, Spreafico R, Wiestler OD, Becker AJ. (2005a) Distinct allelic variants of TSC1 and TSC2 in epilepsy-associated cortical malformations without balloon cells. Journal of Neuropathology And Experimental Neurology 64:629637.
  • Majores M, Schick V, Engels G, Fassunke J, Elger CE, Schramm J, Blümcke I, Becker AJ. (2005b) Mutational and immunohistochemical analysis of ezrin-, radixin-, moesin (ERM) molecules in epilepsy associated glioneuronal lesions. Acta Neuropathologica 110:537546.
  • McClatchey AI. (2003) Merlin and ERM proteins: unappreciated roles in cancer development? Nat Rev Cancer 3:877883.
  • McManus EJ, Alessi DR. (2002) TSC1-TSC2: a complex tale of PKB-mediated S6K regulation. Nature Cell Biology 4:E214216.
  • Miller JR, Hocking AM, Brown JD, Moon RT. (1999) Mechanism and function of signal transduction by the Wnt/beta-catenin and Wnt/Ca2 +pathways. Oncogene 18:78607872.
  • Mischel PS, Nguyen LP, Vinters HV. (1995) Cerebral cortical dysplasia associated with pediatric epilepsy. Review of neuropathologic features and proposal for a grading system. Journal of Neuropathology and Experimental Neurology 54:137153.
  • Miyata H, Chiang AC, Vinters HV. (2004) Insulin signaling pathways in cortical dysplasia and TSC-tubers: tissue microarray analysis. Annals of Neurology 56:510519.
  • Mizuguchi M, Takashima S, Yamanouchi H, Nakazato Y, Mitani H, Hino O. (2000) Novel cerebral lesions in the Eker rat model of tuberous sclerosis: cortical tuber and anaplastic ganglioglioma. Journal of Neuropathology and Experimental Neurology 59:188196.
  • Nellist M, Verhaaf B, Goedbloed MA, Reuser AJ, Van Den Ouweland AM, Halley DJ. (2001) TSC2 missense mutations inhibit tuberin phosphorylation and prevent formation of the tuberin-hamartin complex. Human Molecular Genetics 10:28892898.
  • Paglini G, Kunda P, Quiroga S, Kosik K, Caceres A. (1998) Suppression of radixin and moesin alters growth cone morphology, motility, and process formation in primary cultured neurons. Journal of Cell Biology 143:443455.
  • Palmini A, Lüders HO. (2002) Classification issues in malformations caused by abnormalities of cortical development. Neurosurgery Clinics of North America 13:116, vii.
  • Palmini A, Najm I, Avanzini G, Babb T, Guerrini R, Foldvary-Schaefer N, Jackson G, Luders HO, Prayson R, Spreafico R, Vinters HV. (2004) Terminology and classification of the cortical dysplasias. Neurology 62:S28.
  • Patel S, Barkovich AJ. (2002) Analysis and classification of cerebellar malformations. American Journal of Neuroradiology 23:10741087.
  • Platten M, Meyer Puttlitz B, Blümcke I, Waha A, Wolf HK, Nöthen MM, Louis DN, Sampson JR, Von Deimling A. (1997) A novel splice site associated polymorphism in the tuberous sclerosis 2 (TSC2) gene may predispose to the development of sporadic gangliogliomas. Journal of Neuropathology and Experimental Neurology 56:806810.
  • Potter CJ, Huang H, Xu T. (2001) Drosophila Tsc1 functions with TSC2 to antagonize insulin signaling in regulating cell growth, cell proliferation, and organ size. Cell 105:357368.
  • Povey S, Burley MW, Attwood J, Benham F, Hunt D, Jeremiah SJ, Franklin D, Gillett G, Malas S, Robson EB, et al. (1994) Two loci for tuberous sclerosis: one on 9q34 and one on 16p13. Annals of Human Genetics 58:107127.
  • Roach ES, Gomez MR, Northrup H. (1998) Tuberous sclerosis complex consensus conference: revised clinical diagnostic criteria. Journal of Child Neurology 13:624628.
  • Sawin PD, Theodore N, Rekate HL. (1999) Spinal cord ganglioglioma in a child with neurofibromatosis type 2. Case report and literature review. Journal of Neurosurgery: Spine 90:231233.
  • Takeuchi K, Sato N, Kasahara H, Funayama N, Nagafuchi A, Yonemura S, Tsukita S. (1994) Perturbation of cell adhesion and microvilli formation by antisense oligonucleotides to ERM family members. Journal of Cell Biology 125:13711384.
  • Tapon N, Ito N, Dickson BJ, Treisman JE, Hariharan IK. (2001) The Drosophila tuberous sclerosis complex gene homologs restrict cell growth and cell proliferation. Cell 105:345355.
  • Tassi L, Colombo N, Garbelli R, Francione S, Lo Russo G, Mai R, Cardinale F, Cossu M, Ferrario A, Galli C, Bramerio M, Citterio A, Spreafico R. (2002) Focal cortical dysplasia: neuropathological subtypes, EEG, neuroimaging and surgical outcome. Brain 125:17191732.
  • Taylor DC, Falconer MA, Bruton CJ, Corsellis JA. (1971) Focal dysplasia of the cerebral cortex in epilepsy. Journal of Neurology, Neurosurgery and Psychiatry 34:369387.
  • The European Chromosome 16 Tuberous Sclerosis Consortium. (1993) Identification and characterization of the tuberous sclerosis gene on chromosome 16. Cell 75:13051315.
  • Tsukita S, Yonemura S. (1999) Cortical actin organization: lessons from ERM (ezrin/radixin/moesin) proteins. Journal of Biological Chemistry 274:3450734510.
  • Urbach H, Scheffler B, Heinrichsmeier T, Von Oertzen J, Kral T, Wellmer J, Schramm J, Wiestler OD, Blümcke I. (2002) Focal cortical dysplasia of Taylor's balloon cell type: a clinicopathological entity with characteristic neuroimaging and histopathological features, and favorable postsurgical outcome. Epilepsia 43:3340.
  • Urbach H, Blümcke I, Becker A, Solymosi L. (2003) Malformations of cortical development: Imaging and classification. Klin Neuroradiol 13:163172.
  • Van Slegtenhorst M, De Hoogt R, Hermans C, Nellist M, Janssen B, Verhoef S, Lindhout D, Van Den Ouweland A, Halley D, Young J, Burley M, Jeremiah S, Woodward K, Nahmias J, Fox M, Ekong R, Osborne J, Wolfe J, Povey S, Snell RG, Cheadle JP, Jones AC, Tachataki M, Ravine D, Sampson JR, Reeve MP, Richarson P, Wilmer F, Munro C, Hawkins TL, Sepp T, Ali JBM, Ward S, Green AJ, Yates JRW, Kwiatkowski J, Henske EP, Short MP, Haines JH, Jozwiak S, Kwiatkowski DJ. (1997) Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34. Science 277:805808.
  • Van Slegtenhorst M, Nellist M, Nagelkerken B, Cheadle J, Snell R, Van Den Ouweland A, Reuser A, Sampson J, Halley D, Van Der Sluijs P. (1998) Interaction between hamartin and tuberin, the TSC1 and TSC2 gene products. Human Molecular Genetics 7:10531057.
  • Van Slegtenhorst M, Verhoef S, Tempelaars A, Bakker L, Wang Q, Wessels M, Bakker R, Nellist M, Lindhout D, Halley D, Van Den Ouweland A. (1999) Mutational spectrum of the TSC1 gene in a cohort of 225 tuberous sclerosis complex patients: no evidence for genotype-phenotype correlation. Journal of Medical Genetics 36:285289.
  • Von Deimling A, Fimmers R, Schmidt MC, Bender B, Fassbender F, Nagel J, Jahnke R, Kaskel P, Duerr EM, Koopmann J, Maintz D, Steinbeck S, Wick W, Platten M, Muller DJ, Przkora R, Waha A, Blümcke B, Wellenreuther R, Meyer-Puttlitz B, Schmidt O, Mollenhauer J, Poustka A, Stangl AP, Lenartz D, Von Ammon K. (2000) Comprehensive allelotype and genetic analysis of 466 human nervous system tumors. Journal of Neuropathology and Experimental Neurology 59:544558.
  • Wiebe S, Blume WT, Girvin JP, Eliasziw M. (2001) A randomized, controlled trial of surgery for temporal-lobe epilepsy. New England Journal of Medicine 345:311318.
  • Wilgenbus KK, Milatovich A, Francke U, Furthmayr H. (1993) Molecular cloning, cDNA sequence, and chromosomal assignment of the human radixin gene and two dispersed pseudogenes. Genomics 16:199206.
  • Wilgenbus KK, Hsieh CL, Lankes WT, Milatovich A, Francke U, Furthmayr H. (1994) Structure and localization on the X chromosome of the gene coding for the human filopodial protein moesin (MSN). Genomics 19:326333.
  • Wolf HK, Müller MB, Spänle M, Zentner J, Schramm J, Wiestler OD. (1994) Ganglioglioma: a detailed histopathological and immunohistochemical analysis of 61 cases. Acta Neuropathologica 88:166173.
  • Wolf HK, Birkholz T, Wellmer J, Blümcke I, Pietsch T, Wiestler OD. (1995a) Neurochemical profile of glioneuronal lesions from patients with pharmacoresistant focal epilepsies. Journal of Neuropathology and Experimental Neurology 54:689697.
  • Wolf HK, Wellmer J, Muller MB, Wiestler OD, Hufnagel A, Pietsch T. (1995b) Glioneuronal malformative lesions and dysembryoplastic neuroepithelial tumors in patients with chronic pharmacoresistant epilepsies. Journal of Neuropathology and Experimental Neurology 54:245254.
  • Wolf HK, Roos D, Blümcke I, Pietsch T, Wiestler OD. (1996) Perilesional neurochemical changes in focal epilepsies. Acta Neuropathologica 91:376384.
  • Wolf HK, Buslei R, Blümcke I, Wiestler OD, Pietsch T. (1997) Neural antigens in oligodendrogliomas and dysembryoplastic neuroepithelial tumors. Acta Neuropathologica 94:436443.
  • Xiao GH, Shoarinejad F, Jin F, Golemis EA, Yeung RS. (1997) The tuberous sclerosis 2 gene product, tuberin, functions as a Rab5 GTPase activating protein (GAP) in modulating endocytosis. Journal of Biological Chemistry 272:60976100.